BRIEF-Sierra Oncology granted U.S., EU patents for CHK1 inhibitor SRA737
* Sierra Oncology granted U.S. and EU patents for CHK1 inhibitor SRA737 Source text for Eikon: Further company coverage:
Dec 1 Midland Exploration Inc :
* Midland commences new drilling campaign on the Patris Gold Project Source text for Eikon: Further company coverage:
* Sierra Oncology granted US and EU patents for Chk1 inhibitor SRA737
May 30 U.S. stock index futures were little changed on Tuesday, after the three-day holiday weekend, as investors awaited economic data for clues regarding the health of the economy.